BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 3, 2019
View Archived Issues
Neutrophils have antitumor effects, can improve clinical outcomes
Read More
Endogenous retrovirus has link to MS
Read More
MS-1768 acts as a specific dopamine D2 receptor partial agonist
Read More
Novel zebrafish model to study the role of STUB1 in ataxia
Read More
Dicerna to initiate clinical development of DCR-A1AT for A1AT deficiency-associated liver disease
Read More
FDA grants IND approval for phase I/II study of anti-Fc gamma RllB antibody
Read More
ANT-2681 demonstrates pH-dependent potency and in vitro antibacterial activity
Read More
First clinical efficacy and safety data for 225Ac-DOTATATE in GEP-NET
Read More
Strong immunoprotection with a Zika VLP vaccine in a murine model
Read More
PPNA-40: comparable activity to tigecycline in multidrug-resistant A. baumannii model
Read More
MediSynergics divulges compounds for parasitic diseases
Read More
Daiichi Sankyo discloses new EP300 and/or CBP inhibitors
Read More
Basilea Pharmaceutica patent describes mitochondrial inhibitors
Read More
Leo Pharma describes PDE4 and TNF-alpha release inhibitors
Read More
IDO1 inhibitors reported in Phenex Discovery Verwaltungs patent
Read More
Low-dose mercury causes heart failure in mice
Read More
Data reported from first-in-human ATB200-02 trial of ATB-200/AT-2221 combination in Pompe disease
Read More
Appili Therapeutics to advance antibiotic program
Read More
FDA places clinical hold on phase I trial of ACTR-087 for relapsed/refractory NHL
Read More
Phase III MINISTONE-2 study of Xofluza in children with influenza meets primary endpoint
Read More
Tracon advances phase I/II trial of androgen receptor antagonist TRC-253 in metastatic CRPC
Read More
European Commission approves Dovato for HIV-1 infection
Read More
Algernon's NP-120 reduces fibrosis in in vivo animal model study of IPF
Read More
